Golden Leaf Holdings Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Golden Leaf Holdings Ltd with three other
pharmaceutical manufacturers in North America:
Enzon Pharmaceuticals, Inc.
of the United States
sales of $8.38 million
CanniMed Therapeutics Inc
(9.80 million Canadian Dollars [US$7.88 million]
based in the United States
of which 100%
was Therapeutic Drug Dev).